Abstract:Infantile hemangioma (IH), the most common tumor of infancy, is characterized by an initial proliferation during infancy followed by spontaneous involution over the next 5-10 years, often leaving a fibro-fatty residuum. IH is traditionally considered a tumor of the microvasculature. However, recent data show the critical role of stem cells in the biology of IH with emerging evidence suggesting an embryonic developmental anomaly due to aberrant proliferation and differentiation of a hemogenic endothelium with a neural crest phenotype that possesses the capacity for endothelial, hematopoietic, mesenchymal, and neuronal differentiation. Current evidence suggests a putative placental chorionic mesenchymal core cell embolic origin of IH during the first trimester. This review outlines the emerging role of stem cells and their interplay with the cytokine niche that promotes a post-natal environment conducive for vasculogenesis involving VEGFR-2 and its ligand VEGF-A and the IGF-2 ligand in promoting cellular proliferation, and the TRAIL-OPG anti-apoptotic pathway in preventing cellular apoptosis in IH. The discovery of the role of the renin-angiotensin system in the biology of IH provides a plausible explanation for the programed biologic behavior and the β-blocker-induced accelerated involution of this enigmatic condition. This crucially involves the vasoactive peptide, angiotensin II, that promotes cellular proliferation in IH predominantly via its action on the ATIIR2 isoform. The role of the RAS in the biology of IH is further supported by the effect of captopril, an ACE inhibitor, in inducing accelerated involution of IH. The discovery of the critical role of RAS in IH represents a novel and fascinating paradigm shift in the understanding of human development, IH, and other tumors in general.

[The Distribution and Evolution of Pericytes in Infantile Hemangioma].

Effect of Notch signaling on differentiation of hemangioma-derived pericytes

PDGFR-β (+) Perivascular Cells from Infantile Hemangioma Display the Features of Mesenchymal Stem Cells and Show Stronger Adipogenic Potential in Vitro and in Vivo.

The analysis of cell cycle and apoptosis with flow cytometry in hemangioma of children and its significance

CENPF May Act as a Novel Marker and Highlight the Influence of Pericyte in Infantile Hemangioma

Cell Fate Regulation During the Development of Infantile Hemangioma

Monocytes: A Possible Source of Hemangioma Endothelial Cells

[The Relationship Between the Expression of HIF-1alpha and the Angiogenesis in Infancy Hemangioma].

Stem cell in infantile hemangioma

Expression and significance of hypoxia inducible factor-1α in different phases of hemangioma and vascular malformation in infants and children

Expression of Hypoxia Inducible Factor-1Α, 3α in Hemangioma

Expressions of Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1 in Hemangioma

Biology of Infantile Hemangioma

JAGGED1 Signaling Regulates Hemangioma Stem Cell–to–Pericyte/Vascular Smooth Muscle Cell Differentiation

Role Of Endothelial-Mesenchymal Transition In The Tumorigenesis Of Infantile Hemangioma

Investigative Progress of Pathogenesis of Hemangioma

The role of multipotential stem cells in human infantile hemangioma

The Expression and Significance of Telomerase Reverse Transcriptase(TERT) in Infantile Hemangiomas

A Possible Mechanism of Spontaneous Involution of Infantile Hemangioma

[Expression of bcl-2 and survivin gene products in different stages of vessel differentiation in hemangiomas].

Differentiation of the pericyte in wound healing: The precursor, the process, and the role of the vascular endothelial cell.